Showing results (171-180 of 198) with videos related to
Sort By:
Pageof 20
Journal of Clinical Research in Pediatric Endocrinology|October 8, 2024
Evaluation of Growth Characteristics and Final Height of Cases Diagnosed with Noonan Syndrome on Growth Hormone TreatmentZeynep Şıklar, Merih Berberoğlu, Sirmen Kızılcan Çetin, et al.Hormone Research in Paediatrics|March 30, 2012
The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter studyFirdevs Baş, Feyza Darendeliler, Zehra Aycan, et al.The Journal of Clinical Endocrinology and Metabolism|May 26, 2019
Clinical but Not Histological Outcomes in Males With 45,X/46,XY Mosaicism Vary Depending on Reason for DiagnosisMarie Lindhardt Ljubicic, Anne Jørgensen, Carlo Acerini, et al.Journal of Clinical Research in Pediatric Endocrinology|September 20, 2021
Recommendations for Clinical Decision-making in Children with Type 1 Diabetes and Celiac Disease: Type 1 Diabetes and Celiac Disease Joint Working Group ReportŞükrü Hatun, Buket Dalgıç, Damla Gökşen, et al.The Journal of Clinical Endocrinology and Metabolism|April 8, 2021
Clinical and Hormonal Profiles Correlate With Molecular Characteristics in Patients With 11β-Hydroxylase DeficiencyMelek Yildiz, Emregul Isik, Zehra Yavas Abali, et al.Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation|August 5, 2021
Testosterone Therapy and Its Monitoring in Adolescent Boys with Hypogonadism: Results of an International Survey from the I-DSD RegistryMarianna R Stancampiano, Angela K Lucas-Herald, Jillian Bryce, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|May 29, 2025
Comparison of the clinical characteristics of children with Silver-Russell syndrome genetically confirmed or not and their response to growth hormone therapy: a national multicenter studyİlker Tolga Özgen, Tuğçe Kandemir, Melek Yıldız, et al.Trials|September 15, 2023
SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trialCristina Garcia-Beltran, Rita Malpique, Marianne S Andersen, et al.Pediatrics|August 6, 2014
Changes over time in sex assignment for disorders of sex developmentZofia Kolesinska, S Faisal Ahmed, Marek Niedziela, et al.Journal of Clinical Research in Pediatric Endocrinology|March 25, 2015
Current practice in diagnosis and treatment of growth hormone deficiency in childhood: a survey from TurkeyŞükran Poyrazoğlu, Teoman Akçay, İlknur Arslanoğlu, et al.Pageof 20